Author

G. Hannon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Assay:bulk RNA-seq· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Approach:statistical model· 2

Frequent Co-Authors

A. Aurora· 1 shared A. L. Hughson· 1 shared A. Lujambio· 1 shared B. N. Mills· 1 shared C. A. Stockwell· 1 shared C. J. Johnston· 1 shared C. Jauset· 1 shared C. Riera Domingo· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Aurora

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 30, 2023

Local Delivery of SBRT and IL12 by mRNA Technology Overcomes Immunosuppressive Barriers to Eliminate Pancreatic Cancer

A. L. Hughson, G. Hannon, N. A. Salama…·S. A. Gerber

This paper demonstrates a combination treatment of SBRT and IL-12 mRNA in murine pancreatic tumors, achieving cures in both primary and metastatic models by enhancing T cell responses.

DOI 10.1101/2023.10.30.564833

mousebulk RNA-seq

Cancer BiologybioRxivJan 24, 2021

Heterogeneity in PHGDH protein expression potentiates cancer cell dissemination and metastasis

M. Rossi, G. Doglioni, L. Bornes…·S.-M. Fendt

This study identifies PHGDH protein expression heterogeneity as a driver of breast cancer metastasis by altering metabolic pathways and promoting dissemination.

DOI 10.1038/s41586-022-04758-2

mousehuman

Cancer BiologybioRxivJan 6, 2021

An epigenetic switch regulates the ontogeny of AXL positive/EGFR-TKI resistant cells by modulating miR-335 expression

R. Sordella, D. Pal, P. Safaric Tepes…·G. Hannon

The paper identifies an epigenetic mechanism regulating AXL-positive/Erlotinib-resistant cells through miR-335 expression, suggesting combinatorial therapies for EGFR-mutated NSCLC.

DOI 10.7554/elife.66109

humanbulk RNA-seq